Literature DB >> 3149778

Low dose scopolamine affects discriminability but not rate of forgetting in delayed conditional discrimination.

R C Kirk1, K G White, N McNaughton.   

Abstract

The effect of scopolamine on remembering was examined in a delayed conditional discrimination procedure with rats. Remembering was quantified by a negative exponential function fitted to estimates of discriminability derived from a signal detection type of analysis. This function had two parameters: a measure of initial discriminability of the sample stimuli in the absence of a memory requirement (at zero delay) and a measure of rate of forgetting. Eight rats were trained on an auditory delayed conditional discrimination task until they were showing stable performance. Each rat then received doses of 0, 0.005, 0.014, 0.042, 0.125 and 0.375 mg/kg scopolamine IP in a saline vehicle. There was a highly significant, largely linear, decrease in initial discriminability. This was obvious even at the lowest dose of scopolamine. Poorer memory, as demonstrated by an increase in b, was only apparent at the highest dose. Significant changes in per cent of correct responses were also only obtained at higher doses. These results show that initial discriminability and rate of forgetting are pharmacologically as well as theoretically independent. They suggest that the measure of initial discriminability used here is a particularly sensitive measure of at least some types of cholinergic dysfunction; and they also suggest that effects of scopolamine in other working memory tasks could be more a result of changed stimulus processing than of impairment of memorial processes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3149778     DOI: 10.1007/bf02180037

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  On two types of deviation from the matching law: bias and undermatching.

Authors:  W M Baum
Journal:  J Exp Anal Behav       Date:  1974-07       Impact factor: 2.468

2.  Acquisition of delayed matching in the pigeon.

Authors:  R Berryman; W W Cumming; J A Nevin
Journal:  J Exp Anal Behav       Date:  1963-01       Impact factor: 2.468

3.  The relation between the generalized matching law and signal-detection theory.

Authors:  M C Davison; R D Tustin
Journal:  J Exp Anal Behav       Date:  1978-03       Impact factor: 2.468

4.  Characteristics of forgetting functions in delayed matching to sample.

Authors:  K G White
Journal:  J Exp Anal Behav       Date:  1985-07       Impact factor: 2.468

5.  Attenuation of stimulus sensitivity induced by scopolamine.

Authors:  D M Warburton; K Brown
Journal:  Nature       Date:  1971-03-12       Impact factor: 49.962

6.  Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats.

Authors:  S B Dunnett
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine.

Authors:  R T Bartus; H R Johnson
Journal:  Pharmacol Biochem Behav       Date:  1976-07       Impact factor: 3.533

8.  Cholinergic drug effects on visual discriminations: a signal detection analysis.

Authors:  K S Milar
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Qualitative analysis of scopolamine-induced amnesia.

Authors:  E D Caine; H Weingartner; C L Ludlow; E A Cudahy; S Wehry
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  Delayed stimulus control: recall for single and relational stimuli.

Authors:  K G White; J McKenzie
Journal:  J Exp Anal Behav       Date:  1982-11       Impact factor: 2.468

View more
  15 in total

Review 1.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Effects of cholinergic and non-cholinergic drugs on visual discrimination and delayed visual discrimination performance in rats.

Authors:  J S Andrews; M Grützner; D N Stephens
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 3.  Memory deficits in Alzheimer's disease: the encoding hypothesis and cholinergic function.

Authors:  K Geoffrey White; Angela C Ruske
Journal:  Psychon Bull Rev       Date:  2002-09

4.  Effects of the NMDA antagonists CPP and MK-801 on delayed conditional discrimination.

Authors:  S Tan; R C Kirk; W C Abraham; N McNaughton
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Quantification of the effects of chlorpromazine on performance under delayed matching to sample in pigeons.

Authors:  J E Watson; N M Blampied
Journal:  J Exp Anal Behav       Date:  1989-05       Impact factor: 2.468

6.  Acquisition of matching-to-sample performance in rats using visual stimuli on nose keys.

Authors:  I H Iversen
Journal:  J Exp Anal Behav       Date:  1993-05       Impact factor: 2.468

7.  Marijuana effects on human forgetting functions.

Authors:  Scott D Lane; Don R Cherek; Lori M Lieving; Oleg V Tcheremissine
Journal:  J Exp Anal Behav       Date:  2005-01       Impact factor: 2.468

8.  Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists.

Authors:  K J Stanhope; A P McLenachan; C T Dourish
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

9.  Chlordiazepoxide reduces discriminability but not rate of forgetting in delayed conditional discrimination.

Authors:  S Tan; R C Kirk; W C Abraham; N McNaughton
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  Effects of nicotine and mecamylamine on cognition in rhesus monkeys.

Authors:  Simon N Katner; Sophia A Davis; Amber J Kirsten; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.